Lindbrook Capital’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-1
| Closed | -$147 | – | 2703 |
|
2023
Q2 | $147 | Hold |
1
| – | – | ﹤0.01% | 2660 |
|
2023
Q1 | $411 | Buy |
+1
| New | +$411 | ﹤0.01% | 2639 |
|
2022
Q2 | – | Sell |
-6
| Closed | -$2K | – | 2511 |
|
2022
Q1 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 1945 |
|
2021
Q4 | – | Sell |
-125
| Closed | -$61K | – | 2083 |
|
2021
Q3 | $61K | Buy |
125
+94
| +303% | +$45.9K | 0.02% | 388 |
|
2021
Q2 | $15K | Sell |
31
-17
| -35% | -$8.23K | ﹤0.01% | 881 |
|
2021
Q1 | $33K | Buy |
48
+36
| +300% | +$24.8K | 0.01% | 566 |
|
2020
Q4 | $9K | Sell |
12
-113
| -90% | -$84.8K | ﹤0.01% | 936 |
|
2020
Q3 | $87K | Buy |
+125
| New | +$87K | 0.02% | 233 |
|